Faculty of Medicine, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Faculty of Medicine, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Int J Surg. 2018 Feb;50:35-42. doi: 10.1016/j.ijsu.2017.12.021. Epub 2017 Dec 25.
In patients with hepatocellular carcinoma (HCC) and cirrhosis, laparoscopic hepatectomy (LH) confers short-term benefits over open hepatectomy (OH) but the long-term outcomes of this procedure are unclear. This systematic review aims to compare the long-term survival outcomes of LH and OH for patients with HCC and underlying cirrhosis.
EMBASE, MEDLINE and Scopus databases were searched from date of inception to 7th October 2016. Controlled clinical studies comparing LH to OH for HCC in cirrhotic patients, which reported long-term overall and disease-free survival were included. The studies were evaluated using the MOOSE guidelines and Newcastle-Ottawa Scale. Data were extracted and analysed using a fixed-effects model.
Five non-randomised, retrospective observational studies representing 888 patients were included. LH was associated with significantly lower tumour recurrence [OR: 0.65, 95% CI: 0.48, 0.89]. LH conferred greater overall survival at 1- [HR: 0.41, 95% CI: 0.25, 0.68], 3- [HR: 0.63, 95% CI: 0.46, 0.87] and 5-years [HR: 0.60, 95% CI: 0.45, 0.80]. With LH, there was higher disease-free survival at 1-year [HR: 0.71, 95% CI: 0.53, 0.96], but not at 3- [HR: 0.89, 95% CI: 0.70, 1.14]; and 5-years [HR: 0.85, 95% CI: 0.70, 1.04].
Laparoscopic surgery is associated with comparable postoperative and survival outcomes in patients with HCC and underlying cirrhosis. With careful selection of patients, this approach is safe, feasible and advantageous.
在患有肝细胞癌(HCC)和肝硬化的患者中,腹腔镜肝切除术(LH)比开腹肝切除术(OH)具有短期优势,但该手术的长期结果尚不清楚。本系统评价旨在比较 LH 和 OH 治疗 HCC 和基础肝硬化患者的长期生存结果。
从创建日期到 2016 年 10 月 7 日,我们在 EMBASE、MEDLINE 和 Scopus 数据库中进行了检索。纳入了比较 LH 与 OH 治疗 HCC 合并肝硬化患者的对照临床试验,报告了长期总生存率和无病生存率。研究采用 MOOSE 指南和纽卡斯尔-渥太华量表进行评估。使用固定效应模型提取和分析数据。
纳入了 5 项非随机、回顾性观察研究,共 888 例患者。LH 与肿瘤复发率显著降低相关[比值比(OR):0.65,95%可信区间(CI):0.48,0.89]。LH 可显著提高患者的总生存率,1 年[风险比(HR):0.41,95%CI:0.25,0.68]、3 年[HR:0.63,95%CI:0.46,0.87]和 5 年[HR:0.60,95%CI:0.45,0.80]。LH 可显著提高 1 年的无病生存率[HR:0.71,95%CI:0.53,0.96],但 3 年[HR:0.89,95%CI:0.70,1.14]和 5 年[HR:0.85,95%CI:0.70,1.04]的无病生存率无显著差异。
腹腔镜手术在 HCC 和基础肝硬化患者中具有相似的术后和生存结果。通过仔细选择患者,这种方法是安全、可行且有利的。